Stock ORY ORYZON GENOMICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Delayed BME
Other stock markets
 14:18:19 15/05/2024 BST 		5-day change 1st Jan Change
2.055 EUR +1.23% Intraday chart for Oryzon Genomics S.A. +4.31% +8.85%
05-06 Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat CI
ea5c56ba2.6I5TbZRqabEtQx-7tYoCdPdWfAt93hSvunXXaoWnIwM.mOsHD80NDdhacmXR6t46OoYQBl0_8ybJw0GdXKjKYEKe3z4eyy825BktXg~816a2985e261672d712e85c010fc297c
  1. Stock Market
  2. Equities
  3. ORY Stock
  4. Charts Oryzon Genomics S.A.
  5. News Chart